170.98 USD
↗ 1.90 (1.12%)LIVE (AS OF 10:41 AM EDT)
Guardant Health, Inc. Common Stock
GHNASDAQ • USD
Market: OPEN
Shares of Guardant Health, Inc. Common Stock (GH) are trading at $170.98. GH shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". This is driven by a robust Altman Z-Score, exceptional Return on Equity (203.5%) and a bullish Golden Cross on the moving averages. On the valuation front, GH trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Oct 23, 2026.
Open?$170.10
High?$176.64
Low?$166.18
Prev. Close?$169.08
Volume?339.3K
Avg. Volume?1.9M
VWAP?$170.40
Rel. Volume?0.18x
Bid / Ask
Bid?$170.52 × 100
Ask?$171.49 × 100
Spread?$0.97
Midpoint?$171.01
Valuation & Ratios
Market Cap?22.7B
Shares Out?134.2M
Float?127.0M
Float %?94.6%
P/E Ratio?N/A
P/B Ratio?-101.81
EPS?-$3.38
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Themes
Employees
2.5K
Market Cap
22.7B
Industry
SERVICES-MEDICAL LABORATORIES
Website
Listed
2018-10-04
Address
3100 HANOVER STREET
PALO ALTO, CA 94304
Phone: 855-698-8887
PALO ALTO, CA 94304
Phone: 855-698-8887
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?100
Momentum?83
Short Sent.?49
Piotroski F-Score?4/9Mixed
Altman Z-Score?7.52Safe
Confidence?66%Moderate
Short InterestHigh
Short % of Float?9.38%Elevated
Short Interest?11.9M
Days to Cover?6.2
Free Float127.0M
Avg Daily Volume1.9M
Settlement Date2026-09-30
Financial Health
Current Ratio?4.03Strong
Quick Ratio?3.71Strong
Cash Ratio?3.11Strong
Debt/Equity?-6.74Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-101.81CHEAP▾
S&P97
P/S?19.18HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-53.6CHEAP▾
S&P97
EV/Sales?19.56HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?203.5%STRONG▾
Peers50
S&P97
ROA?-23.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-240724000
Enterprise Value?$23.1B
Fundamentals ratios updated end of day